These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 10837182)

  • 1. Liposomal amphotericin B and amphotericin B-deoxycholate show different immunoregulatory effects on human peripheral blood mononuclear cells.
    Reyes E; Cardona J; Prieto A; Bernstein ED; Rodríguez-Zapata M; Pontes MJ; Alvarez-Mon M
    J Infect Dis; 2000 Jun; 181(6):2003-10. PubMed ID: 10837182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of high-dose liposomal amphotericin B: efficacy and tolerance.
    Garbino J; Adam A
    Acta Biomed; 2006; 77 Suppl 4():19-22. PubMed ID: 17370566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The novel lipid delivery system of amphotericin B: drug profile and relevance to clinical practice.
    Rust DM; Jameson G
    Oncol Nurs Forum; 1998; 25(1):35-48. PubMed ID: 9460772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of no synthase expression and tumor necrosis factor alpha production in macrophages by amphotericin B lipid carriers.
    Larabi M; Legrand P; Appel M; Gil S; Lepoivre M; Devissaguet J; Puisieux F; Barratt G
    Antimicrob Agents Chemother; 2001 Feb; 45(2):553-62. PubMed ID: 11158754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the leishmanicidal activity of fungizone, liposomal AmB and amphotericin B incorporated into egg lecithin-bile salt mixed micelles.
    Ramos H; Brajtburg J; Marquez V; Cohen BE
    Drugs Exp Clin Res; 1995; 21(6):211-6. PubMed ID: 8907695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amphotericin B deoxycholate (d-AMB) use in cases with febrile neutropenia and fungal infections: lower toxicity with suitable premedication.
    Oto OA; Paydas S; Disel U; Yavuz S; Seydaoglu G
    Mycoses; 2007 Mar; 50(2):135-9. PubMed ID: 17305778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of aerosolized liposomal versus deoxycholate amphotericin B formulations for prevention of invasive fungal infections following lung transplantation: a retrospective study.
    Lowry CM; Marty FM; Vargas SO; Lee JT; Fiumara K; Deykin A; Baden LR
    Transpl Infect Dis; 2007 Jun; 9(2):121-5. PubMed ID: 17461997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of high doses of liposomal amphotericin B in the treatment of experimental aspergillosis.
    Martín MT; Gavaldà J; López P; Gomis X; Ramírez JL; Rodríguez D; Len O; Jordano Q; Ruiz I; Rosal M; Almirante B; Pahissa A
    J Antimicrob Chemother; 2003 Dec; 52(6):1032-4. PubMed ID: 14613950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicity, stability and pharmacokinetics of amphotericin B in immunomodulator tuftsin-bearing liposomes in a murine model.
    Khan MA; Owais M
    J Antimicrob Chemother; 2006 Jul; 58(1):125-32. PubMed ID: 16709592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of high loading doses of liposomal amphotericin B in the treatment of experimental invasive pulmonary aspergillosis.
    Gavaldà J; Martín T; López P; Gomis X; Ramírez JL; Rodríguez D; Len O; Puigfel Y; Ruiz I; Pahissa A
    Clin Microbiol Infect; 2005 Dec; 11(12):999-1004. PubMed ID: 16307554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic and hemolytic evaluation of in-situ liposomal preparation containing amphotericin - beta complexed with different chemically modified beta - cyclodextrins.
    Chakraborty KK; Naik SR
    J Pharm Pharm Sci; 2003; 6(2):231-7. PubMed ID: 12935435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Water-soluble amphotericin B-polyvinylpyrrolidone complexes with maintained antifungal activity against Candida spp. and Aspergillus spp. and reduced haemolytic and cytotoxic effects.
    Charvalos E; Tzatzarakis MN; Van Bambeke F; Tulkens PM; Tsatsakis AM; Tzanakakis GN; Mingeot-Leclercq MP
    J Antimicrob Chemother; 2006 Feb; 57(2):236-44. PubMed ID: 16361329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corneal concentrations following systemic administration of amphotericin B and its lipid preparations in a rabbit model.
    Goldblum D; Rohrer K; Frueh BE; Theurillat R; Thormann W; Zimmerli S
    Ophthalmic Res; 2004; 36(3):172-6. PubMed ID: 15103209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of liposomal amphotericin B formulation.
    Gulati M; Bajad S; Singh S; Ferdous AJ; Singh M
    J Microencapsul; 1998; 15(2):137-51. PubMed ID: 9532520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aerosolized liposomal amphotericin B: prediction of lung deposition, in vitro uptake and cytotoxicity.
    Fauvel M; Farrugia C; Tsapis N; Gueutin C; Cabaret O; Bories C; Bretagne S; Barratt G
    Int J Pharm; 2012 Oct; 436(1-2):106-10. PubMed ID: 22814222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In vivo activity of liposomal amphotericin B against Exophiala dermatitidis in a murine lethal infection model].
    Kashimoto S; Takemoto K; Yamamoto Y; Kanazawa K
    Jpn J Antibiot; 2010 Jun; 63(3):265-72. PubMed ID: 20976882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of the efficacy of liposomal amphotericin B and amphotericin B deoxycholate against six species of Zygomycetes in a murine lethal infection model.
    Takemoto K; Yamamoto Y; Kanazawa K
    J Infect Chemother; 2010 Dec; 16(6):388-95. PubMed ID: 20535522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifungal activity of amphotericin B conjugated to carbon nanotubes.
    Benincasa M; Pacor S; Wu W; Prato M; Bianco A; Gennaro R
    ACS Nano; 2011 Jan; 5(1):199-208. PubMed ID: 21141979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma protein binding of amphotericin B and pharmacokinetics of bound versus unbound amphotericin B after administration of intravenous liposomal amphotericin B (AmBisome) and amphotericin B deoxycholate.
    Bekersky I; Fielding RM; Dressler DE; Lee JW; Buell DN; Walsh TJ
    Antimicrob Agents Chemother; 2002 Mar; 46(3):834-40. PubMed ID: 11850269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative therapeutic efficacy of a novel lyophilized amphotericin B lecithin-based oil-water microemulsion and deoxycholate-amphotericin B in immunocompetent and neutropenic mice infected with Candida albicans.
    Brime B; Molero G; Frutos P; Frutos G
    Eur J Pharm Sci; 2004 Aug; 22(5):451-8. PubMed ID: 15265515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.